» Articles » PMID: 33098023

Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2020 Oct 24
PMID 33098023
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lifestyle changes, including physical activity, are the cornerstones of the treatment of nonalcoholic fatty liver disease (NAFLD). For unclear reasons, most NAFLD patients do not achieve the recommended amount of weekly activity.

Aims: Our aim was to measure perceived barriers to physical activity and enablers to exercise intervention.

Methods: Consecutive subjects aged 18-70 with NAFLD were prospectively enrolled. An exercise motivation questionnaire was administered to assess current behaviors and perceived barriers.

Results: Eighty-seven subjects (60% female) were enrolled with mean age 52 years and mean body mass index (BMI) 34.5 kg/m. Metabolic comorbidities were common: 49% had hyperlipidemia, 42% hypertension, and 40% diabetes. The majority (75%) did not achieve ≥ 150 min/week of physical activity. Ninety-one percent agreed that activity was important in improving NAFLD; 88% desired to be more active. Lack of exercise resources and education from treating provider (47%), physical discomfort during exercise (44%), and time constraints (32%) were the most common barriers. Rates of fitness tracker (34%), gym (33%), exercise program (33%), and personal trainer (17%) use were low.

Conclusions: While nearly all subjects with NAFLD identify physical activity to be important and desire to be more active, only a few meet activity recommendations. This discordance is due to a perceived lack of resources and education, physical discomfort, and time constraints. Better understanding of these barriers and behaviors are important to improve morbidity and mortality in NAFLD. Future behavioral research removing the identified barriers is of great importance to global public health and should be prioritized.

Citing Articles

Acceptability and perceptions of a 12-week telehealth exercise programme with dietary advice to increase plant-based protein in people with non-alcoholic fatty liver disease: a programme evaluation using mixed methods.

Freer C, George E, Tan S, Abbott G, Paris T, Daly R BMJ Open. 2025; 15(3):e086604.

PMID: 40074279 PMC: 11904327. DOI: 10.1136/bmjopen-2024-086604.


The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C Hepatol Int. 2025; .

PMID: 40016576 DOI: 10.1007/s12072-024-10774-3.


Impact of In-Person and Mobile Exercise Coaching on Psychosocial Factors Affecting Exercise Adherence in Inactive Women With Obesity: 20-Week Randomized Controlled Trial.

Gjestvang C, Kalhovde J, Mauseth Tangen E, Clemm H, Haakstad L J Med Internet Res. 2025; 27:e68462.

PMID: 39999434 PMC: 11897673. DOI: 10.2196/68462.


Challenges in Promoting Physical Activity for Managing MASLD in Canadian Children: Insights and Barriers.

Kehar M, Huerta-Saenz L, Strain J, Kawesa S, Yaraskavitch J, Stine J Dig Dis Sci. 2025; .

PMID: 39961965 DOI: 10.1007/s10620-025-08910-6.


Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Rajewski P, Ciescinski J, Rajewski P, Suwala S, Rajewska A, Potasz M Biomedicines. 2025; 13(1).

PMID: 39857800 PMC: 11760440. DOI: 10.3390/biomedicines13010217.


References
1.
Zhang H, He J, Pan L, Ma Z, Han C, Chen C . Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Intern Med. 2016; 176(8):1074-82. DOI: 10.1001/jamainternmed.2016.3202. View

2.
Williams F, Vallance A, Faulkner T, Towey J, Durman S, Kyte D . Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. Liver Transpl. 2019; 25(7):995-1006. DOI: 10.1002/lt.25442. View

3.
Chen H, Ferrando A, Dunn M, Kim W, Duarte-Rojo A . Cadence From Physical Activity Trackers for Monitoring of Home-Based Exercise Intensity in Advanced Liver Disease. Liver Transpl. 2020; 26(5):718-721. DOI: 10.1002/lt.25745. View

4.
Stine J, Rinella M . Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?. Am J Gastroenterol. 2017; 112(5):752-754. DOI: 10.1038/ajg.2017.60. View

5.
Weinstein A, Escheik C, Oe B, Price J, Gerber L, Younossi Z . Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease. PM R. 2015; 8(1):28-34. DOI: 10.1016/j.pmrj.2015.06.001. View